Modulação redox da homeostase de células musculares lisas através de estimuladores do sistema NADPH oxidase

• Autor(a) principal: Silva, João Alfredo de Moraes Gomes
• Data de Publicação: 2011
• Tipo de documento: Tese
• Idioma: por
• Título da fonte: Biblioteca Digital de Teses e Dissertações da UERJ
• Texto Completo: http://www.bdtd.uerj.br/handle/1/16164
• topic: Cardiovascular diseases; NAPHox; Heme Oxygenase; Integrins; Doenças cardiovasculares; NADPHox; Heme oxigenasse; Integrinas; Aterosclerose; Doenças cardiovasculares Fatores de risco; NADPH oxidade; Heme; Integrinas Fisiologia; CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA

Cardiovascular diseases represent the major mortality reason in western countries. Among these diseases, atherosclerosis is the most prominent one, which is characterized by vascular smooth muscle cell (VSMC) accumulation. The pathological effect of VSMC in response to different stimuli is able to induce VSMC dysfunctions. Notably, this cardiovascular disease occurs mainly in sinuous vessels with turbulent blood flow, which may lead to hemolysis and consequent free heme accumulation. Furthermore, in atherogenesis the adhesion molecule, mainly integrins, were of crucial importance during the VSMC response. In this work our aim was to elucidate the effect of free heme in VSMC, as well the molecular mechanisms underlying this process. In a second part, we investigated the role of α1ß1 integrin in Angiotensin II (Ang II) effect on VSMC. We observed that free heme is able to induce VSMC proliferation in a Reactive Oxygen Species (ROS) derived from NADPHoxidase (NADPHox) dependent manner. Additionally, heme activates proliferation-relationed redox-sensitive signaling routes, such as MAPKinases and the transcription factor NFκB. It was also observed a critical crosstalk between NADPHox and heme oxygenase (HO) system, once heme induces HO-1 expression and VSMC pretreatment with HO inhibitors increased heme proliferative effect and ROS production. Accordingly, we observed that the counter-regulatory effect promoted by HO occurs due heme metabolites: biliverdin, bilirubin and carbon monoxide. Finally, when both NADPHox and HO system were blocked, heme had no effect on VSMC proliferation. In a second part, we observed that the chemotactic effect of Ang II on VSMC was abolished when the cells were pretreated with the α1ß1 integrin ligand, the disintegrin Obtustatin. Then, we observed that the Ang II effect on FAK activation and actin-ILK colocalization is integrin α1ß1 dependent, which possibly activates PKCα, once we observed that the ROS production induced by Ang II was inhibited by Obtustatin. We demonstrated by western blotting that ILK induction by Ang II is dependent of α1ß1 integrin and we also observed that Obtustatin inhibited the uncoupling of ILK to FAK, once Obtustatin blocked the FAK phosphorylation induced by Ang II (crucial process to ILK uncoupling). We also observed that Ang II induced, via α1ß1 integrin, AKT phosphorylation, and p21 expression reducement, probably via ILK. Corroborating these data we demonstrated that the pretreatment with Obt induced G1 phase arrest and diminishment of VSMC proliferation treated with AngII. Thus we showed that free heme induces VSMC activation via NADPHox, which is elegantly counter-regulated by HO-1. Furthermore, we suggest that α1ß1 integrin may be an important target molecule to the development of more effective therapeutic interventions in atherosclerosis.